Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: A report of 2 cases

Archives of Dermatology

Volumn 147, Issue 10, 2011, Pages 1228-1230

  Chu, Derek H ^a   Van Voorhees, Abby S ^a   Rosenbach, Misha ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ISOTRETINOIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PSORALEN; TUMOR NECROSIS FACTOR INHIBITOR; USTEKINUMAB;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; PUVA; REMISSION; RHEUMATOID ARTHRITIS; SWEATING; TREATMENT DURATION; ULTRAVIOLET A RADIATION;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROHN DISEASE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOGLOBULIN G; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; PSORIASIS; PUVA THERAPY; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 80054722142     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.275     Document Type: Article

References (5)

1. de Gannes GC, Ghoreishi M, Pope J, et al. Psoriasis and pustular dermatitis triggered by TNF-alpha inhibitors in patients with rheumatologic conditions. Arch Dermatol. 2007;143(2):223-231. (Pubitemid 46294587)
2. Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9(1):1-14.
3. Ubriani R, Van Voorhees AS. Onset of psoriasis during treatment with TNFalpha antagonists: a report of 3 cases. Arch Dermatol. 2007;143(2):270-272. (Pubitemid 46294603)
4. Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum. 2010;40(3):233-240.
5. Gerdes S, Franke J, Domm S, Mrowietz U. Ustekinumab in the treatment of palmoplantar pustulosis. Br J Dermatol. 2010;163(5):1116-1118.